Sang­amo joins biotech mi­gra­tion to Oys­ter Point with new HQ

Join­ing the flock of biotechs head­ed to Oys­ter Point, gene ther­a­py com­pa­ny Sang­amo Ther­a­peu­tics is build­ing a new head­quar­ters and man­u­fac­tur­ing fa­cil­i­ty in the Bay …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.